Evaluation of Osteo-Buddy in Improving Osteoporosis Knowledge

SingHealth Polyclinics

Status: Not yet enrolling

Conditions: Osteoporosis Risk; Osteoporosis, Postmenopausal

Treatments: Other: Osteo-Buddy; Other: Usual Care

Study type: Interventional

Funder types: Other

Identifiers

NCT07034131

2025-0064

Details and patient eligibility

About

This is a pilot randomised controlled trial (RCT) to evaluate the use of a Virtual Health Assistant (VHA) named Osteo-Buddy in improving the knowledge of osteoporosis in older women.

Full description

This study will involve evaluating the preliminary effectiveness and feasibility outcomes of the use of Osteo-Buddy, a Virtual Health Assistant (VHA), in improving the knowledge of osteoporosis in women aged 50 and above.

Enrollment: 80 estimated patients

Sex: Female

Ages: 50+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age 50 and above
• Medium or high Osteoporosis Self-Assessment Tool for Asians (OSTA) score
• Not undertaken Bone Mineral Density (BMD) scan
• Never been treated with anti-osteoporosis medications such as bisphosphonates (e.g. alendronate, risendronate, ibandronate, zolendronate, pamidronate) or denosumab
• Able to read and speak English
• Currently use and own a smartphone where Osteo-Buddy can be used

Exclusion criteria

• Known terminal illness
• Visual, hearing and/or cognitive impairment or mental illness that renders them unable to provide informed consent

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

80 participants in 2 patient groups

Intervention

Experimental group

Description:

use of Osteo-Buddy for 4 weeks

Treatment:

Other: Usual Care

Other: Osteo-Buddy

Control

Experimental group

Description:

usual care - access to digitalised educational materials titled 'Healthy Bones'

Treatment:

Other: Usual Care